Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 98 entries
View as:

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00403104 Org: User:
Start: 11/30/06 End: 12/31/08 Due: 12/31/09

A Phase 1 Study of ONO-2020 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05507515 Org: User:
Start: 07/29/22 End: 12/24/23 Due: 12/24/24

Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01748344 Org: User:
Start: 11/30/12 End: - Due: -

A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)

Phase: N/A Priority: Normal
NCT ID: NCT02083289 Org: User:
Start: 05/31/14 End: - Due: -

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02454387 Org: User:
Start: 05/31/15 End: 04/30/16 Due: 04/30/17

Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02267343 Org: User:
Start: 10/31/14 End: 01/31/21 Due: 01/31/22

A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01705275 Org: User:
Start: 01/31/13 End: - Due: -

Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03155061 Org: User:
Start: 04/19/17 End: 03/31/27 Due: 03/31/28

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01379586 Org: User:
Start: 06/30/11 End: - Due: -

Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00212693 Org: User:
Start: 01/31/04 End: - Due: -

Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)

Phase: N/A Priority: Normal
NCT ID: NCT00924586 Org: User:
Start: 06/30/09 End: - Due: -

A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06622226 Org: User:
Start: 11/27/24 End: 12/31/29 Due: 12/31/30

Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788

Phase: N/A Priority: Normal
NCT ID: NCT03849872 Org: User:
Start: 02/27/19 End: 04/02/19 Due: 04/02/20

Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00417326 Org: User:
Start: 12/31/06 End: - Due: -

The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06540261 Org: User:
Start: 09/23/21 End: 12/31/27 Due: 12/31/28

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00694941 Org: User:
Start: 06/30/08 End: - Due: -

A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of ONO-2808-01 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04578028 Org: User:
Start: 08/19/20 End: 10/07/21 Due: 10/07/22

A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03571594 Org: User:
Start: 06/07/18 End: 05/16/19 Due: 05/16/20

Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: a Nationwide Study

Phase: N/A Priority: Normal
NCT ID: NCT06714370 Org: User:
Start: 12/31/24 End: 12/31/26 Due: 12/31/27

Study of ONO-2506 in Patients With Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00229177 Org: User:
Start: 09/30/05 End: 09/30/08 Due: 09/30/09

ONO-7913 Phase I Study (ONO-7913)

Phase: N/A Priority: Normal
NCT ID: NCT04403308 Org: User:
Start: 07/28/20 End: 01/13/22 Due: 01/13/23

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06570031 Org: User:
Start: 11/09/21 End: 07/31/25 Due: 07/31/26

Study of ONO-1078 in Patients With Chronic Sinusitis

Phase: N/A Priority: Normal
NCT ID: NCT00410735 Org: User:
Start: 12/31/06 End: - Due: -

Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04504760 Org: User:
Start: 07/10/20 End: 03/18/21 Due: 03/18/22

MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01517321 Org: User:
Start: - End: - Due: -